rss
Br J Ophthalmol 88:962-967 doi:10.1136/bjo.2003.029058
  • Perspective

The Zimmerman-McLean-Foster hypothesis: 25 years later

Table 1

 Reported outcomes with alternative therapies for uveal melanoma (comparative studies)

Author Year Study groups Outcome Rate*
COMS, Collaborative Ocular Melanoma Study.
*Difference not statistically significant in any study.
Adams24 1988 Enucleation 5 year tumour related mortality 0.77–1.07
Plaque (rate ratio)
Seddon28 1990 Enucleation 5 year survival rate 68%
Proton beam 81%
Augsburger30 1990 Plaque Actuarial 5 year survival 82%
Resection probability 85%
Foulds8 1991 Enucleation Melanoma related mortality 70%
Resection 76%
Kroll29 1998 Plaque 5 year all cause mortality 23%
Helium ion 26%
Augsburger25 1999 Enucleation Cumulative 15 year survival 57%
Plaque 62%
COMS26 2001 Enucleation 5 year all cause mortality 19%
Plaque 18%
COMS33 1998 Enucleation ± radiation 5 year all-cause survival 57%–62%
Puusaari27 2003 Plaque 5 year all-cause survival 62%

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.